Download Files:
Products Details
Product Description
– DGKα-IN-8 (Example 51) is a DGKα inhibitor (IC50=22.491 nM; EC50=0.256 nM). DGKα-IN-8 can be used to study cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection[1].
Web ID
– HY-156578
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C23H19ClF3N5O
References
– [1]Julian A Codelli, et al. Diacylglyercol kinase modulating compounds. Patent WO2022271659A1.
CAS Number
– 2886717-70-8
Molecular Weight
– 473.88
SMILES
– FC1=CC(N(CC(F)F)C2=NC3=C(C4=C2C=CC(Cl)=C4)N(C)N=N3)=CC(C#CC(C)(C)O)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer; Infection
Solubility
– 10 mM in DMSO
Target
– DGK;HIV
Pathway
– Anti-infection;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
